Social Capital Suvretta Holdings Corp III Cl A (DNAC)

$9.28 0.00 (0.00%)
16:00 EDT DNAC Stock Quote Delayed 30 Minutes
Eddie Pan

DNAC Stock: 11 Things to Know Ahead of the ProKidney SPAC Merger

By Eddie Pan, InvestorPlace Financial News Writer
Palihapitiya's SPAC with ProKidney is expected to close during Q3 of this year. Here's what you need to know about the biotech company.

7 Worst SPACs for Smart Investors to Skip in 2022

DNAC Stock Alert: Chamath Palihapitiya’s SPAC Preps for ProKidney Merger

Are Chamath Palihapitiya’s 4 New Biotech SPACs Worth a Look?

More Articles
Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap -
PE Ratio -
EPS -
Volume (Avg. Vol.)
Day's Range -
52-Week Range -
Dividend & Yield N/A (N/A)